J&J U.S. PHARMACEUTICAL SALES CLIMB 15.6% TO $496 MIL. IN FIRST QUARTER; SCHERING CLARITIN SALES ARE $130 MIL. IN FIRST NINE MONTHS ON U.S. MARKET